trial · primary record
topical ruxolitinib 1.5% cream
Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2026-10-12 |
| Primary endpoint | Reduction in Body Surface Area (BSA) From Day 1 and Day 28 |
| Registry ID | NCT03954236 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:24.593Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03954236
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.